OUR SOLUTIONS / Medium vessel stroke

The only device designed for distals

TIGERTRIEVER™ 13 goes further in the brain to be tough on clots and gentle on the vessels.

Request a demo

OUR SOLUTIONS / Medium vessel stroke

The only device designed for distals

TIGERTRIEVER™ 13 goes further in the brain to be tough on clots and gentle on the vessels.

Request a demo

OUR SOLUTIONS / Medium vessel stroke

The only device designed for distals

TIGERTRIEVER™ 13 goes further in the brain to be tough on clots and gentle on the vessels.

Request a demo

OUR SOLUTIONS / Medium vessel stroke

The only device designed for distals

TIGERTRIEVER™ 13 goes further in the brain to be tough on clots and gentle on the vessels.

Request a demo

Strokes in smaller arteries can still cause disabling deficits, and clot-dissolving drugs work less than half the time.1,2,3


Yet, these vessels are at increased risk for hemorrhage during treatment.

Strokes in smaller arteries can still cause disabling deficits, and clot-dissolving drugs work less than half the time.1,2,3


Yet, these vessels are at increased risk for hemorrhage during treatment.

Protect the vessel with TIGERTRIEVER™ 13

Most complications occur during retrieval, as tension can cause vessel stretching, pain, and injury.


TIGERTRIEVER™ is the only device that can remove force before and during retrieval to reduce the potential for injury. 

Protect the vessel with TIGERTRIEVER™ 13

Most complications occur during retrieval, as tension can cause vessel stretching, pain, and injury.


TIGERTRIEVER™ is the only device that can remove force before and during retrieval to reduce the potential for injury. 

The comfort

of control

Traditional 3 mm stent retrievers exert higher forces as vessels narrow. Active thrombectomy with TIGERTRIEVER™ 13 adjusts to meet the constraints of the anatomy.

Adjust to the anatomy with TIGER 13. 

Deliver and retrieve with the lowest forces4,5

Go the distals

Simplify distal reach and tortuous paths with 30% lower delivery profile & delivery force than other 3 mm retrievers.4

Go the distals

Simplify distal reach and tortuous paths with 30% lower delivery profile & delivery force than other3 mm retrievers.4

ADVANCING THE FIELD OF STROKE


Rapid Medical™ has pioneered a new frontier in MVO treatment with randomized evidence demonstrating that TIGERTRIEVER™ 13 significantly improves blood flow to the brain with a strong safety profile compared with medical management. The DISTALS Trial brings long-needed clarity to an underserved market representing nearly half of ischemic strokes.


View the results
Clinical evidence
Product overview
How it works
In-Practice
Clinical evidence

PRODUCT OVERVIEW

The world’s first and only adjustable stent retriever, TIGERTRIEVER™ is designed with active, responsive technology for patient-specific procedures.

SPECIFICATIONS


*Not all products are available in all countries.
Place an order Ask a product question Request an IFU

HOW IT WORKS

1 PENETRATE the clot with active integration

2 ADJUST with complete visibility

3 RELAX to relieve vessel traction

Place an order Ask a product question Request an IFU
Webinars banner

WEBINARS

Physician-led webinars are available to view on-demand. To watch a recording, please submit a request here.

Request to view
DR. ALEX SOLICH | Stockholm, Sweden | TIGERTRIEVER™ 13
First-pass distal revascularization with active thrombectomy
View case report →
DR. RAN BRAUNER | Tel Aviv, Israel | TIGERTRIEVER™ 13
First-pass recanalization in a distal M2 occlusion
View case report →

*TIGERTRIEVER™ 13 is indicated for LVOs in the US. Refer to Instructions for Use for detailed indications.

1. Waqas M, Kuo CC, Dossani RH, et al. Mechanical thrombectomy versus intravenous thrombolysis for distal large-vessel occlusion: a systematic review and meta-analysis of observational studies. Neurosurg Focus. 2021;51(1):E5. doi:10.3171/2021.4.FOCUS21139

2. Ospel JM, Menon BK, Demchuk AM, et al. Clinical Course of Acute Ischemic Stroke Due to Medium Vessel Occlusion With and Without Intravenous Alteplase Treatment. Stroke. 2020;51(11):3232-3240. doi:10.1161/STROKEAHA.120.030227

3. Seners P, Turc G, Maier B, Mas JL, Oppenheim C, Baron JC. Incidence and predictors of early recanalization after intravenous thrombolysis: a systematic review and meta‐analysis. Stroke. 2016;47:2409‐2412.

4-5 Data on file

6. Wang, Maud, et al. "The Anch'Or Harpoon Technique With a Manually Expandable Stentretriever (Tigertriever 13), a Technical Note." Frontiers in Neurology, vol. 13, 2022, p. 934690, https://doi.org/10.3389/fneur.2022.934690